Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
暂无分享,去创建一个
A. Harris | K. Stȩpniewska | K. Stepniewska | M. Greenall | Kenneth G. C. Smith | R. Leek | E. R. Horak | N. Klenk | R. Leek | S. LeJeune | K. Smith | N. Stuart | A. L. Harris | M. Greenall | K. Stepniewska | N. Stuart | K. Smith | S. Lejeune | E. Horak | A. Harris | N. Klenk | AdrianL. Harris
[1] L. Tabár,et al. Breast cancer treatment and natural history: new insights from results of screening , 1992, The Lancet.
[2] A. Harris,et al. Novel growth regulatory factors and tumour angiogenesis. , 1991, European journal of cancer.
[3] D. Lane,et al. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. , 1990, The EMBO journal.
[4] I. Hart,et al. Biology of tumour metastasis , 1992, The Lancet.
[5] J. Starkey,et al. Mast‐cell‐deficient W/Wv mice exhibit A decreased rate of tumor angiogenesis , 1988, International journal of cancer.
[6] A. Srivastava,et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. , 1988, The American journal of pathology.
[7] M. Crumpton,et al. Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. , 1989, Journal of clinical pathology.
[8] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[9] L. Liotta,et al. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.
[10] A. Harris,et al. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer. , 1991, Oncogene.
[11] R Bicknell,et al. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. , 1992, Journal of clinical pathology.
[12] M. Greaves,et al. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[13] J. Folkman,et al. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.
[14] E. Goldmann. The Growth of Malignant Disease in Man and the Lower Animals, with special reference to the Vascular System. , 1907, Proceedings of the Royal Society of Medicine.
[15] D. Mason,et al. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. , 1990, Journal of clinical pathology.
[16] S. Albelda,et al. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule , 1991, The Journal of cell biology.
[17] I. Hart,et al. Metastasis and angiogenesis. , 1990, Acta oncologica.
[18] J. Farndon,et al. EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER , 1989, The Lancet.
[19] W. Gregory,et al. Natural history of breast cancer , 1992, The Lancet.
[20] H M Jensen,et al. Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer. , 1982, Science.